Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

September 30, 2031

Conditions
PreeclampsiaHypertensive Disorder of Pregnancy
Interventions
DEVICE

Arterial applanation tonometry

Arterial applanation tonometry will be performed at the carotid and femoral level by the PulsePen device (Software WPulsePen version 2.3.1, DiaTecne, Milan, Italy), while the subject is lying in the horizontal position and after 5 minutes of rest.

DEVICE

In vivo endothelial glycocalyx measurement

The in vivo microscopy (GlycoCheck system) is performed in the sublingual capillaries during the morning, with the participant sitting on a chair. The sublingual capillaries are visualized using an SDF video microscope (Capiscope handheld, KK Research technology Ltd).

DIAGNOSTIC_TEST

Serum markers of angiogenesis and endothelial dysfunction

ELISA assays to measure serum circulating markers of angiogenesis and endothelial dysfunction (ANG-1, ANG-2, ET-1, ICAM-1 and VCAM-1).

DIAGNOSTIC_TEST

Blood chemistry test

Immunochemistry analysis of serum levels of uric acid, total cholesterol, LDL-cholesterol, HDL-cholesterol, Triglycerides, Lipoprotein (a)

DIAGNOSTIC_TEST

Serum xanthine oxidase activity

Serum xanthine oxidase (XO) activity will be assessed in blood samples measuring the ability of XO to produce uric acid

Trial Locations (1)

40124

Cardiovascular Internal Medicine Unit, IRCCS University Hospital of Bologna, Bologna, Italy, Bologna

All Listed Sponsors
collaborator

University of Bologna

OTHER

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT05999851 - Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy | Biotech Hunter | Biotech Hunter